Company: LBRX
Filing Date: 2025-09-08
Form Type: S-1/A
Source: 0001193125-25-197877
Chunk: 413

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-09-08
Form: S-1/A
Chunk 413
---
 Employment Agreement, dated June 12, 2024, between Roger Sawhney and the Registrant                                |
| 10.22+** |     | Separation Agreement, dated May 6, 2025, between Roger Sawhney and the Registrant                                            |
| 10.23+   |     | Non-Employee Director Compensation Policy                                                                                    |
| 10.24**  |     | Form of Amended and Restated Royalty Participation Agreement by and between the Registrant and certain holders               |
| 10.25†** |     | Lease Agreement, dated May 20, 2024, between the Registrant and One Penn Plaza LLC                                           |
| 21.1**   |     | List of Subsidiaries                                                                                                         |
| 23.1     |     | Consent of BDO USA, P.C., Independent Registered Public Accounting Firm                                                      |

II-4

| Exhibit 
 No.     |     | Description                                                |
| 23.2    |     | Consent of Cooley LLP (included in Exhibit 5.1)            |
| 24.1**  |     | Power of Attorney (see signature page)                     |
| 99.1    |     | Consent of Rekha Hemrajani to be Named as Director Nominee |
| 99.2    |     | Consent of William Kane to be Named as Director Nominee    |
| 107     |     | Filing Fee Table                                           |

| ** | Previously filed. |

| + | Indicates management contract or compensatory plan. |

| † | Certain schedules and exhibits to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request. |

(b) Financial statement schedules. No financial statement schedules are provided because the information called for is not required or is shown either in the financial statements or the notes thereto. Item 17. Undertakings. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid